Transplantation Proceedings
Volume 33, Issue 7 , Pages 3067-3069 , November 2001

Mechanism of action of the calcineurin inhibitors

  • P.F. Halloran

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dr P.F. Halloran, Director, Division of Nephrology and Immunology, University of Alberta, 250 Heritage Medical Research Centre, Edmonton, Alberta T6G 2S2, Canada
    • Department of Medicine, Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada

References 

  1. Canadian Multicentre Transplant Study Group . N Engl J Med. 1983;309:809
  2. European Multicentre Trial . Lancet. 1982;10:57
  3. Vincenti F, Laskow DA, Neylan JF, et al.  Transplant. 1996;61:1576
  4. European FK506 Multicentre Liver Study Group . Lancet. 1994;344:423
  5. The U.S. Multicenter FK506 Liver Study Group . N Engl J Med. 1994;331:1110
  6. Calne RY, White DJG, Thiru S, et al.  Lancet. 1978;30:1323
  7. Elliot JF, Lin Y, Mizel SB, et al.  Science. 1984;226:1439
  8. Kröonke M, Leonard WJ, Depper JM, et al.  Proc Natl Acad Sci USA. 1984;81:5214
  9. Clipstone NA, Crabtree GR. Nature. 1992;357:695
  10. Fruman DA, Klee CB, Bierer BE, et al.  Proc Natl Acad Sci USA. 1992;89:3686
  11. Kino T, Hatanaka H, Miyata S, et al.  J Antibiot. 1987;40:1256
  12. Griffith JP, Kim JL, Kim EE, et al.  Cell. 1995;82:507
  13. Ivery MTG. Bioorganic and Medicinal Chemistry. 1999;7:1389
  14. Batiuk TD, Kung L, Halloran PF. J Clin Invest. 1997;100:1894
  15. Batiuk TD, Pazderka F, Enns J, et al.  Transplant. 1996;61:158
  16. Batiuk TD, Urmson J, Vincent D, et al.  Transplant. 1996;61:1618
  17. Batiuk TD, Pazderka F, Enns J, et al.  J Clin Invest. 1995;96:1254
  18. Batiuk TD, Pazderka F, Halloran PF. Transplant. 1995;59:1400
  19. Kung L, Halloran PF. Transplant. 2000;70:327
  20. Halloran PF, Helms LM, Kung L, et al.  Transplant. 1999;68:1356

☆ This research was supported by operating grants from the Canadian Institutes of Health Research, the Kidney Foundation of Canada, Novartis Pharmaceuticals Canada, Inc, The Muttart Foundation, and The Royal Canadian Legion. Dr Halloran holds a Canada Research Chair in Life Sciences Related to Human Health and Disease.

PII: S0041-1345(01)02308-9

Transplantation Proceedings
Volume 33, Issue 7 , Pages 3067-3069 , November 2001

Article Tools